HYDTF — Hydreight Technologies Inc.

OTC · Unknown · Unknown · CIK 1958389 ·
Last close
$2.92
Market Cap
$155.90M
52W High
$3.79
52W Low
$1.61
ADV30
38,400
Next earnings
Hydreight Technologies Inc. provides operates in the digital health technology sector in the United States. The company develops a proprietary telemedicine service that allows users to book confidential health and wellness, and/or medical services through a mobile application. It also provides consulting and advice in setting up health and wellness services, including assistance with finding experienced advisors in the areas of medical and privacy law, among others; medical liability insurance; pharmaceutical IV programs vetted by duly licensed pharmacists; procedural guides with respect to various services, such as wide ranging IV therapy treatments, GLP1, NAD, Botox, and fillers; and hiring, on-boarding, training, marketing, branding, payroll, and other accounting services. In addition, the company offers an online pharmacy, which allow its network of medical practitioners to purchase pharmacy products from federally regulated pharmacies. Hydreight Technologies Inc. is headquartered in Las Vegas, Nevada.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 14,948,859 3,238,219 1,232,726 1,261,646 33,751,814 15,649,232 14,052,370
Sep 2025 10,519,538 2,330,320 688,302 361,888 22,269,164 18,635,165 12,796,108
Jun 2025 5,376,519 1,930,202 212,833 49,867 8,642,891 6,104,118 5,229,406
Mar 2025 4,540,122 1,504,465 78,798 20,903 8,325,733 6,043,629 5,176,671

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,866,263
Investing CF
$-1,679,041
Financing CF
$18,002,543
CapEx
$-1,515,049
Dividends Paid
Buybacks
EPS Diluted TTM
$0.01
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-7,436,332
Inventory
$0
Receivables
$1,805,823
ST Investments
EBIT TTM
$1,921,182
Pretax Income TTM
$1,113,967
Interest Exp TTM
$586,354
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$35,385,040
EBITDA
$1,847,355
Free Cash Flow
$-4,159,538
Enterprise Value
$147,418,656
Total Cash
$15,649,232
Total Debt
$8,769,552
Shares Out
53,390,430
Trailing EPS
$0.03
Book Value
$0.29
ROE
18.9%
ROA
4.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 35,385,038 2,212,659 1,694,304 33,751,814 14,052,370 -1,866,263
Dec 2024 16,044,716 292,171 -405,169 3,108,755 4,877,498 856,922
Dec 2023 11,509,496 -1,465,134 -1,937,351 2,604,008 4,434,925 -402,177
Dec 2022 4,268,431 -1,959,403 -5,995,220 2,892,433 3,249,274 -329,602

News headlines (Yahoo Finance, 1h cache)

Hydreight Technologies Announces Timing of Q1 2026 Financial Results and Investor Webcast
2026-05-26 11:30 · Yahoo
Victory Square Technologies Reports Fiscal 2025 Results Highlighting Platform Scaling, Healthcare Infrastructure Growth and Portfolio Momentum
2026-05-01 04:14 · Yahoo
Hydreight Technologies Completes $300,000 Strategic Investment in Insu Therapeutics; Shares Rose Near 6% Today
2026-03-13 20:47 · Yahoo
Hydreight Technologies Closes Strategic Investment in Insu Therapeutics
2026-03-13 20:15 · Yahoo
Hydreight Announces Normal Course Issuer Bid
2026-03-09 12:00 · Yahoo
Hydreight Technologies Invests in Insu Therapeutics to Advance Needle-Free Peptide Delivery Technology
2026-03-05 18:22 · Yahoo
Hydreight Technologies Inc. Announces Strategic Investment in Insu Therapeutics to Advance Needle-Free Peptide Delivery Technology
2026-03-05 13:00 · Yahoo
Hydreight Technologies Issues Fiscal 2026 Revenue Guidance of ≈ $150 Million and Provides Q1 2026 Outlook
2026-02-02 13:00 · Yahoo
Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering
2026-01-27 13:30 · Yahoo
Hydreight Announces $10 Million Bought Deal Private Placement
2026-01-15 21:51 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.